Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Carcinoma, Hepatocellular × Cisplatin × Clear all

Phase

Phase 2 10 Phase 3 4 Phase NA 3 Phase 1 3 Phase 1/2 2 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 10 Esophageal Neoplasms 7 Nasopharyngeal Carcinoma 6 Lung Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Squamous Cell Carcinoma of Head and Neck 5 Pancreatic Neoplasms 4 Head and Neck Neoplasms 4 Cholangiocarcinoma 4 Biliary Tract Neoplasms 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Neoplasm Metastasis 3 Gallbladder Neoplasms 3 Carcinoma 3 Stomach Neoplasms 2 Oropharyngeal Neoplasms 2 Mesothelioma 2 Endometrial Neoplasms 2 Carcinoma, Transitional Cell 2 Breast Neoplasms 2 Bile Duct Neoplasms 2 Adenocarcinoma Of Esophagus 2 Triple Negative Breast Neoplasms 1 Thymoma 1 Thymic epithelial tumor 1 Sarcoma 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Pathologic Complete Response 1 Osteosarcoma 1

Interventions

Sorafenib 7 lenvatinib 5 apatinib 5 Oxaliplatin 5 Fluorouracil 5 sintilimab 4 Leucovorin 4 Folfox protocol 4 Bevacizumab 4 camrelizumab 3 atezolizumab 3 Capecitabine 3 tremelimumab 2 durvalumab 2 Radiosurgery 2 Nivolumab 2 Neoadjuvant Therapy 2 Hepatectomy 2 Gemcitabine 2 Ethiodized Oil 2 Drug Therapy 2 pirarubicin 1 liposomal doxorubicin 1 lanreotide 1 halofantrine 1 donafenib 1 coenzyme Q10 1 budigalimab 1 Vitamin B 6 1 Tyrosine Kinase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00843934 2012-10-19

ACE500

Nihon University

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡